Philip Tsai, Chief Technology Officer at Immunome Inc. (IMNM), bought 21,000 shares at $9.43 ($198K) on 2024-11-21, disclosed to the SEC on 2024-11-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |